Trade Names: | |
Synonyms: | |
Status: | Approved (1953) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | FD171B778Y |
Parent Compound: | HYDRALAZINE |
InChI Key | ZUXNZUWOTSUBMN-UHFFFAOYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C8H9ClN4 |
Molecular Weight | 196.64 |
AlogP | 0.92 |
Hydrogen Bond Acceptor | 4.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 1.0 |
Polar Surface Area | 63.83 |
Molecular species | BASE |
Aromatic Rings | 2.0 |
Heavy Atoms | 12.0 |
Targets | EC50(nM) | IC50(nM) | Kd(nM) | Ki(nM) | Inhibition(%) | |
---|---|---|---|---|---|---|
Enzyme
Hydrolase
|
- | - | - | 1900-5012 | - | |
Transcription factor
Nuclear receptor
Nuclear hormone receptor subfamily 1
Nuclear hormone receptor subfamily 1 group I
Nuclear hormone receptor subfamily 1 group I member 2
|
450 | - | - | - | - | |
Transporter
Electrochemical transporter
SLC superfamily of solute carriers
SLC21/SLCO family of organic anion transporting polypeptides
|
- | - | - | - | 115 |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Alzheimer Disease | 3 | D000544 | ClinicalTrials |
Heart Failure | 2 | D006333 | ClinicalTrials |
Cerebral Hemorrhage | 2 | D002543 | ClinicalTrials |
Macular Degeneration | 2 | D008268 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 31672 |
ChEMBL | CHEMBL542541 |
EPA CompTox | DTXSID1044645 |
FDA SRS | FD171B778Y |
PubChem | 9351 |
SureChEMBL | SCHEMBL36271 |